Laxai Pharma - 34 Year Stock Price History | LAXAF

Historical daily share price chart and data for Laxai Pharma since 1989 adjusted for splits and dividends. The latest closing stock price for Laxai Pharma as of October 04, 2023 is 0.00.
  • The all-time high Laxai Pharma stock closing price was 13.50 on November 08, 1993.
  • The Laxai Pharma 52-week high stock price is 0.00, which is % above the current share price.
  • The Laxai Pharma 52-week low stock price is 0.00, which is % below the current share price.
  • The average Laxai Pharma stock price for the last 52 weeks is 0.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Laxai Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 0.0001 0.0001 0.0001 0.0001 0.0001 0.00%
2022 0.0021 0.0050 0.0050 0.0001 0.0001 -98.00%
2021 0.0110 0.0055 0.0249 0.0032 0.0050 -9.09%
2020 0.0118 0.0195 0.0500 0.0030 0.0055 -71.65%
2019 0.0241 0.0070 0.1388 0.0045 0.0194 1663.64%
2018 0.0011 0.0008 0.0039 0.0006 0.0011 -35.29%
2017 0.0012 0.0007 0.0020 0.0004 0.0017 183.33%
2016 0.0012 0.0012 0.0080 0.0005 0.0006 -50.00%
2015 0.0016 0.0027 0.0027 0.0011 0.0012 -55.56%
2014 0.0023 0.0045 0.0045 0.0012 0.0027 8.00%
2013 0.0031 0.0021 0.0074 0.0011 0.0025 19.05%
2012 0.0058 0.0010 0.0120 0.0001 0.0021 110.00%
2011 0.0094 0.0098 0.0500 0.0010 0.0010 -88.89%
2010 0.0670 0.0400 0.2500 0.0056 0.0090 -85.00%
2009 0.0485 0.0400 0.0700 0.0110 0.0600 100.00%
2008 0.3731 0.9000 0.9412 0.0300 0.0300 -96.70%
2007 1.1547 1.3500 1.7000 0.8000 0.9100 -36.36%
2006 0.8291 0.6500 2.6400 0.4700 1.4300 90.67%
2005 0.6859 0.7200 1.0990 0.5000 0.7500 17.19%
2004 0.9649 1.1800 1.4900 0.6000 0.6400 -43.86%
2003 0.8409 0.4400 1.7000 0.2500 1.1400 159.09%
2002 0.4348 0.5300 0.6600 0.2000 0.4400 -21.43%
2001 0.7511 0.8750 1.0312 0.4800 0.5600 -28.32%
2000 1.8700 1.1250 3.8438 0.7812 0.7812 -16.67%
1999 1.0104 0.8750 1.5000 0.7500 0.9375 7.14%
1998 1.2984 1.5000 2.0000 0.8438 0.8750 -56.25%
1997 1.9484 2.5000 3.0000 1.5000 2.0000 -20.00%
1996 3.7929 3.8752 5.5000 2.0000 2.5000 -37.50%
1995 6.2820 6.5000 8.2500 3.7500 4.0000 -36.00%
1994 9.1408 12.5000 12.5000 6.0000 6.2500 -47.92%
1993 10.1815 9.2500 13.5000 8.2500 12.0000 41.18%
1992 6.1822 5.7520 9.5000 4.5000 8.5000 61.84%
1991 4.4890 1.7520 7.5000 1.2520 5.2520 199.77%
1990 1.4064 7.0000 7.0000 0.3760 1.7520 -74.97%
Sector Industry Market Cap Revenue
Medical Medical Services $0.000B $0.000B
Laxai Pharma Ltd., formerly known as NexGen Biofuels Ltd., is a clinical research company. The Company, through its wholly owned subsidiary OSR Holding Corp., provides integrated services across the drug development spectrum in the United States. Its services include biostatistics, data management (EDC, Hybrid and Paper), CDISC consulting, medical writing, monitoring, regulatory, drug safety, and training. Laxai Pharma Ltd. is based in Tampa, Florida.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.390B 25.39
Elevance Health (ELV) United States $84.947B 10.96
CVS Health (CVS) United States $77.596B 9.64
Cencora (COR) United States $56.866B 19.78
DiDi Global (DIDIY) China $22.921B 34.79
Natera (NTRA) United States $21.460B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.549B 13.28
EUROFINS SCIENT (ERFSF) Luxembourg $12.465B 0.00
CochLear (CHEOY) Australia $11.562B 0.00
Revvity (RVTY) United States $10.871B 18.71
ICON (ICLR) Ireland $10.610B 9.86
Viatris (VTRS) United States $10.094B 3.47
Doximity (DOCS) United States $9.727B 45.30
Avantor (AVTR) United States $8.961B 13.02
HealthEquity (HQY) United States $8.748B 43.04
Medpace Holdings (MEDP) United States $8.582B 22.79
Sonic Healthcare (SKHHY) Australia $8.220B 0.00
Charles River Laboratories (CRL) United States $6.810B 13.35
Amplifon S.p.A (AMFPF) Italy $4.966B 27.18
Bausch + Lomb (BLCO) Canada $4.171B 24.58
BrightSpring Health Services (BTSG) United States $4.074B 37.71
Sotera Health (SHC) United States $3.528B 20.05
Surgery Partners (SGRY) United States $2.954B 38.42
Alignment Healthcare (ALHC) United States $2.920B 0.00
Concentras Parent (CON) United States $2.761B 15.96
Organon (OGN) United States $2.376B 2.52
Ardent Health Partners (ARDT) United States $2.127B 9.07
GeneDx Holdings (WGS) United States $1.997B 76.91
Premier (PINC) United States $1.896B 14.39
Progyny (PGNY) United States $1.765B 38.85
PACS (PACS) United States $1.558B 0.00
GoodRx Holdings (GDRX) United States $1.368B 27.36
Teladoc Health (TDOC) United States $1.242B 0.00
Pediatrix Medical (MD) United States $1.190B 9.05
Establishment Labs Holdings (ESTA) $1.067B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.982B 15.33
Agilon Health (AGL) United States $0.923B 0.00
Nutex Health (NUTX) United States $0.911B 13.77
AMN Healthcare Services Inc (AMN) United States $0.822B 7.70
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.658B 4.43
InnovAge Holding (INNV) United States $0.545B 0.00
Enhabit (EHAB) United States $0.529B 43.54
LifeMD (LFMD) United States $0.524B 0.00
Auna S.A (AUNA) Luxembourg $0.484B 10.90
SBC Medicals (SBC) United States $0.477B 0.00
Sonida Senior Living (SNDA) United States $0.471B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.400B 0.00
Oncology Institute (TOI) United States $0.269B 0.00
Performant Healthcare (PHLT) United States $0.220B 0.00
Beauty Health (SKIN) United States $0.213B 0.00
KindlyMD (NAKA) United States $0.151B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.142B 23.17
OncoCyte (OCX) United States $0.093B 0.00
So-Young (SY) China $0.090B 0.00
Sera Prognostics (SERA) United States $0.063B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
IceCure Medical (ICCM) Israel $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Biodesix (BDSX) United States $0.051B 0.00
Pheton Holdings (PTHL) China $0.038B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
Basel Medical Group (BMGL) Singapore $0.020B 0.00
ModivCare (MODV) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00